These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Immunohistochemical prognostic criteria in xeroderma pigmentosum. Karakok M; Turkmen A; Bekerecioglu M; Koçer NE Int J Dermatol; 2010 Nov; 49(11):1266-71. PubMed ID: 21038547 [TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of apoptosis-related Bcl-2 protein and its correlation with proliferation indices (Ki67, PCNA), tumor suppressor genes (p53, pRb), the oncogene c-erbB-2, sex steroid hormone receptors and other clinicopathological features, in normal, hyperplastic and neoplastic endometrium. Mitselou A; Ioachim E; Kitsou E; Vougiouklakis T; Zagorianakou N; Makrydimas G; Stefanaki S; Agnantis NJ In Vivo; 2003; 17(5):469-77. PubMed ID: 14598611 [TBL] [Abstract][Full Text] [Related]
10. The use of immunostaining for bcl-2 and CD34 and the lectin peanut agglutinin in differentiating between basal cell carcinomas and trichoepitheliomas. Basarab T; Orchard G; Russell-Jones R Am J Dermatopathol; 1998 Oct; 20(5):448-52. PubMed ID: 9790103 [TBL] [Abstract][Full Text] [Related]
11. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293 [TBL] [Abstract][Full Text] [Related]
13. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Smith KJ; Williams J; Corbett D; Skelton H Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620 [TBL] [Abstract][Full Text] [Related]
14. CD10 expression in trichoepithelioma and basal cell carcinoma. Pham TT; Selim MA; Burchette JL; Madden J; Turner J; Herman C J Cutan Pathol; 2006 Feb; 33(2):123-8. PubMed ID: 16420307 [TBL] [Abstract][Full Text] [Related]
15. Expressions of p53, cyclinD1 and histopathological features in basal cell carcinomas. Koseoglu RD; Sezer E; Eyibilen A; Aladag I; Etikan I J Cutan Pathol; 2009 Sep; 36(9):958-65. PubMed ID: 19187116 [TBL] [Abstract][Full Text] [Related]